Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Sun Pharma, Eli Lilly Lead Latest Rush of Healthcare M&A
This article is for subscribers only. Hi, welcome to the Bloomberg Deals newsletter. We're starting the new week with a look at some big transactions spanning healthcare and oil and gas. Elsewhere, there's the latest on Hong Kong's largest equity…
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition
Sun Pharmaceutical Industries Ltd. signage is displayed outside the company's corporate office in Mumbai. © 2014 Bloomberg Finance LP Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi —has agreed to…
Ascendis Pharma A/S (ASND): Billionaire Joe Edelman Is Bullish on This Stock
We just covered the Billionaire Joe Edelman's 10 Stock Picks with Huge Upside Potential and Ascendis Pharma A/S (NASDAQ:ASND) ranks 9th on this list. The primary catalyst for hedge fund interest in Ascendis Pharma A/S (NASDAQ:ASND) stock over the…
Watch Bernstein's Liang on China's Edge in Pharma Sector
Bernstein's Liang on China's Edge in Pharma Sector China has been closing the gap with the US in biotech and pharmaceutical research, with the proportion of studies being conducted by Chinese scientists increasing. Rebecca Liang, a senior analyst…
Sun Pharma Secures Bridge Loan for $12 Billion Organon Purchase
Sun Pharmaceutical Industries Ltd. has lined up a short-term loan to help finance its $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the transaction. At least three banks —…
Sun Pharma's Dilip Shanghvi on Organon Acquisition: Debt, China Market & Biosimilars
Sun Pharmaceutical Industries' executive chairman Dilip Shanghvi shares his mixed feelings of happiness and anxiety regarding the company's $11.75 billion acquisition of US-based Organon & Co, a strategic move set to expand Sun Pharma's global…
Pharma bets a little-known type of cholesterol will underpin its next blockbuster heart drugs
Novartis, Amgen and Eli Lilly are among the pharmaceutical companies developing drugs to lower levels of a particularly bad form of cholesterol called Lp(a) and potentially prevent heart attacks. Lp(a) levels are almost entirely genetically…
Indian Stock Markets Rebound: Sensex Jumps 639 Points, Nifty Up on Global Cues, Sun Pharma & RIL Rally
Indian benchmark stock indices Sensex and Nifty staged a significant rebound, snapping a three-day losing streak, fuelled by strong performances from Reliance Industries and Sun Pharma, coupled with positive global market trends and easing…
Indian Stock Markets Rebound: Sun Pharma Acquisition, Global Cues Drive Gains
Indian benchmark indices Sensex and Nifty staged a significant rebound in early trade, buoyed by Sun Pharma's major acquisition of US-based Organon & Co and positive global market trends, ending a three-day period of decline. Benchmark indices…
Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal
Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women's health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years. Sun Pharma will pay $14 per Organon share in cash, giving the…
Sun Pharma to Acquire Organon for $11.75 Billion, Expanding Global Footprint
Sun Pharmaceutical Industries Ltd is set to acquire US-based Organon & Co for a staggering $11.75 billion, a strategic move poised to significantly expand its global footprint and elevate its standing among the world's top pharmaceutical companies.
Sun Pharma Founder Says 'Debt-Averse, Not Risk-Averse' After $12 billion Organon Buy
Welcome to India Edition, Bloomberg's daily dive into what's moving the worlds of business, markets and politics in this dynamic, fast-paced economy. I'm Menaka Doshi. If you didn't receive this directly in your inbox, you can subscribe here, and…
Should You Trust AI Coaching for Pharma Reps?
AI coaching is no longer a side initiative for Pharma teams. Field leaders are under pressure to do more with smaller teams, tighter access to HCPs, and more digital-first calls. When every visit is short and closely monitored by compliance teams…
Indian drugmaker Sun Pharma to buy U.S. firm Organon in $11.75 billion deal
Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organon for $14.00 per share. The acquisition will…
Sun Pharma To Purchase US-listed Organon In A Nearly $11.8 billion Deal
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about $11.75 billion including debt, in one of India's biggest outbound deals. The acquisition would help Sun Pharma further expand its women's…
Receive a Daily briefing on Pharma Industry News
Get Started